CytoDyn Inc.
CYDY
$0.2926
-$0.0034-1.15%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.90M | 16.40M | 21.34M | 24.92M | 3.11M |
| Total Receivables | 2.00M | 2.00M | 2.00M | 2.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 252.00K | 513.00K | 635.00K | 570.00K | 463.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.72M | 2.07M | 663.00K | 247.00K | 7.24M |
| Total Current Assets | 17.88M | 20.98M | 24.63M | 27.74M | 10.82M |
|
|
|||||
| Total Current Assets | 17.88M | 20.98M | 24.63M | 27.74M | 10.82M |
| Net Property, Plant & Equipment | 130.00K | 163.00K | 196.00K | 230.00K | 264.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 39.00K | 44.00K | 48.00K | 53.00K | 57.00K |
| Total Assets | 18.05M | 21.19M | 24.88M | 28.02M | 11.14M |
|
|
|||||
| Total Accounts Payable | 14.69M | 15.13M | 14.24M | 14.16M | 29.56M |
| Total Accrued Expenses | 20.22M | 20.26M | 20.18M | 19.17M | 17.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.34M | 27.28M | 28.67M | 29.06M | 29.94M |
| Total Finance Division Other Current Liabilities | 8.27M | 7.90M | 7.53M | 7.16M | 7.09M |
| Total Other Current Liabilities | 8.27M | 7.90M | 7.53M | 7.16M | 7.09M |
| Total Current Liabilities | 70.52M | 70.57M | 70.63M | 69.56M | 84.18M |
|
|
|||||
| Total Current Liabilities | 70.52M | 70.57M | 70.63M | 69.56M | 84.18M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 34.00K | 69.00K | 105.00K | 141.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 43.57M | 43.57M | 43.57M | 43.57M | 43.57M |
| Total Liabilities | 114.09M | 114.17M | 114.27M | 113.23M | 127.89M |
|
|
|||||
| Common Stock & APIC | 791.74M | 788.85M | 787.68M | 787.09M | 774.77M |
| Retained Earnings | -887.79M | -881.83M | -877.07M | -872.30M | -891.53M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -96.04M | -92.98M | -89.39M | -85.21M | -116.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -96.04M | -92.98M | -89.39M | -85.21M | -116.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -96.04M | -92.98M | -89.39M | -85.21M | -116.76M |
|
|
|||||